▮ DFV TERMINAL
--:--:-- UTC SIGN IN
F1 Terminal / EPDU

EPDU — ENTERPRISE PRODUCTS PARTNERS L.P.

—
NYSE · Utilities · Gas Utilities · CIK 1061219 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express; catheter care under the Fibrilin brand; and Sodium Heparin Rovi. In addition, the company offers contract-manufacturing services comprising compounding, sterile filling and terminal sterilisation, inspection, installation of safety devices, labelling, packaging, serialisation and aggregation, for different injectable pharmaceutical forms, such as prefilled syringes, vials and cartridges, as well as manufacturing and packaging services for solid products. Further, it offers low-molecular-weight heparin, Okedi, and Rolcya; and develops Letrozole SIE and Risperidone QUAR. Its products are used for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. The company was incorporated in 1946 and is headquartered in Pozuelo de Alarcón, Spain. Laboratorios Farmaceúticos Rovi, S.A. operates as a subsidiary of Norbel Inversiones, S.L.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 13,775,000,000 26,121,000,000 1,780,000,000 1,417,000,000 77,168,000,000 583,000,000 48,436,000,000
Dec 2023 11,998,000,000 23,076,000,000 1,695,000,000 1,318,000,000 70,982,000,000 180,000,000 43,309,000,000
Dec 2022 15,468,000,000 29,647,000,000 1,712,000,000 1,360,000,000 68,108,000,000 76,000,000 41,485,000,000
Dec 2021 10,832,000,000 20,626,000,000 1,513,000,000 1,153,000,000 67,526,000,000 2,820,000,000 42,197,000,000

Annual Trend (SEC EDGAR, last 10y)

Revenues vs Net Income (last 10y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 49,715,000,000 6,929,000,000 5,529,000,000 77,168,000,000 48,436,000,000 — —
Dec 2023 58,186,000,000 6,907,000,000 5,487,000,000 70,982,000,000 43,309,000,000 — —
Dec 2022 40,807,000,000 6,103,000,000 4,634,000,000 68,108,000,000 41,485,000,000 — —
Dec 2021 27,200,000,000 5,035,000,000 3,775,000,000 67,526,000,000 42,197,000,000 — —
Dec 2020 32,789,200,000 6,078,700,000 4,591,300,000 64,106,700,000 39,802,600,000 — —
Dec 2019 36,534,200,000 5,408,600,000 4,172,400,000 61,733,200,000 36,969,200,000 — —
Dec 2018 9,298,500,000 1,138,500,000 900,700,000 56,969,800,000 33,116,300,000 — —
Dec 2017 7,320,400,000 1,031,600,000 760,700,000 54,418,100,000 31,870,900,000 — —
Dec 2016 5,005,300,000 915,600,000 661,200,000 52,194,000,000 30,147,000,000 — —
Dec 2015 7,472,500,000 896,000,000 636,100,000 48,802,200,000 28,507,100,000 — —

TTM Snapshot

Revenues TTM
$52,073,000,000
NetIncome TTM
$5,248,000,000
OpCashFlow TTM
$0
Assets (Latest)
$77,168,000,000
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
WMB WILLIAMS COMPANIES, INC. $88.15B $72.08 —
NGG NATIONAL GRID PLC $81.44B $81.84 —
EPD ENTERPRISE PRODUCTS PARTNERS L.P. $80.59B $37.25 —
TRP TC ENERGY CORP $72.29B $69.39 —
KMI KINDER MORGAN, INC. $71.06B $31.94 —

Recent Insider Activity

No insider activity indexed for this ticker.
SEC EDGAR filings → · StockAnalysis.com → · OpenInsider →